Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica
- Status
- TERMINATED
- Phase
- PHASE3
Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA
- Status
- TERMINATED
- Phase
- PHASE3
Epidemiological Study of Fabry Disease in Taiwan Young Stroke Patients
- Status
- UNKNOWN
- Phase
- N/A
First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute Pharyngitis
- Status
- COMPLETED
- Phase
- PHASE3
Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)
- Status
- COMPLETED
- Phase
- PHASE3
Investigating the Effects of Lipid-therapy Intensification With Alirocumab on Endothelial Function, Carotid Arteries, Lipoprotein Particle Subfractions, Inflammation and Post-prandial Lipemia
- Status
- TERMINATED
- Phase
- PHASE4
Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy
- Status
- COMPLETED
- Phase
- PHASE2
BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis
- Status
- RECRUITING
- Phase
- N/A
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE2
Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
- Status
- TERMINATED
- Phase
- PHASE3
Eliglustat on Gaucher Disease Type IIIB
- Status
- COMPLETED
- Phase
- NA
REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Study to Evaluate Improvements of the Quality of Sleep With NOVANUIT® Triple Action in Healthy Volunteers With Sleep Disorders
- Status
- COMPLETED
- Phase
- PHASE1
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE3
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Efpeglenatide on Cardiovascular Outcomes
- Status
- TERMINATED
- Phase
- PHASE3